Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 5/20 | 0.49 |
| ▸ | RAB9A | P51151 | 5/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.43 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17190124 | 0.83 | EPHX1 (0.64) | EPHX1EPHX2HTTALDH1A1 | |
| SCHEMBL17190122 | 0.78 | RAB9A (0.72) | SMN1; SMN2NPC1RAB9APKMALOX15 | |
| SCHEMBL10891352 | 0.76 | PKM (0.56) | SMN1; SMN2NPC1RAB9APKMALOX15 | |
| SCHEMBL10892796 | 0.76 | RAB9A (0.59) | SMN1; SMN2NPC1RAB9APKMALOX15 | |
| SCHEMBL5779764 | 0.76 | KMT2A (0.52) | NPC1RAB9AEPHX1MEN1KMT2A | |
| SCHEMBL5565031 | 0.76 | CNR1 (0.55) | SMN1; SMN2NPC1RAB9AALOX15EPHX1 | |
| SCHEMBL6719494 | 0.75 | MAPT (0.50) | SMN1; SMN2NPC1RAB9AEPHX1MEN1 | |
| SCHEMBL15601909 | 0.75 | MAPT (0.53) | SMN1; SMN2NPC1RAB9AALOX15EPHX1 | |
| SCHEMBL2597849 | 0.74 | HTT (0.64) | SMN1; SMN2EPHX1EPHX2MEN1KMT2A | |
| SCHEMBL6719504 | 0.74 | MAPT (0.49) | EPHX1EPHX2MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7229479-B2 | Method of coloring porous material | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-06-12 | — | — | US | disclosed |
| US-20060162095-A1 | Method of colouring porous material | CIBA SPECIALTY CHEMICALS CORP. | 2006-07-27 | — | — | US | disclosed |
| EP-1534226-A1 | METHOD OF COLOURING POROUS MATERIAL | Ciba SC Holding AG (CH) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004019897-A1 | METHOD OF COLOURING POROUS MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-03-11 | — | — | WO | disclosed |
| US-6673966-B2 | FOR USE IN HAIR COLORING FORMULATIONS | THE PROCTER & GAMBLE COMPANY | 2004-01-06 | — | — | US | disclosed |
| US-20020100127-A1 | Novel coupler for use in oxidative hair dyeing | WELLA OPERATIONS US, LLC | 2002-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060162095-A1 | Method of colouring porous material | ACR, HLA-C, TYR | SMN1; SMN2 4115/4885NPC1 2665/4885RAB9A 4054/4885 |
| US-20020100127-A1 | Novel coupler for use in oxidative hair dyeing | CBR1, CBR3, PYCR1 | SMN1; SMN2 4874/4885NPC1 4510/4885RAB9A 4190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.